Exact Sciences, Pfizer to Comarket Cologuard

Exact Sciences and Pfizer announced today that they have entered into an agreement to copromote Exact’s colorectal cancer screening test Cologuard.

“This partnership marks a turning point in the fight to end colorectal cancer,” Exact Chairman and CEO Kevin Conroy said in a statement. “Pfizer is joining Exact Sciences’ mission of eradicating colorectal cancer by helping detect the disease at its earliest, most treatable stages.”

Source: https://www.genomeweb.com/business-news/exact-sciences-pfizer-comarket-cologuard